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Protein biosynthesis is energetically costly, is tightly regulated and is coupled to stress
conditions including glucose deprivation. RNA polymerase III (RNAP III)-driven transcription
of tDNA genes for production of tRNAs is a key element in efﬁcient protein biosynthesis.
Here we present an analysis of the effects of altered RNAP III activity on the
Saccharomyces cerevisiae proteome and metabolism under glucose-rich conditions. We
show for the ﬁrst time that RNAP III is tightly coupled to the glycolytic system at the
molecular systems level. Decreased RNAP III activity or the absence of the RNAP III nega-
tive regulator, Maf1 elicit broad changes in the abundance proﬁles of enzymes engaged in
fundamental metabolism in S. cerevisiae. In a mutant compromised in RNAP III activity,
there is a repartitioning towards amino acids synthesis de novo at the expense of glycolytic
throughput. Conversely, cells lacking Maf1 protein have greater potential for glycolytic ﬂux.
Introduction
Regulation of glycolytic ﬂux is a long-standing, but still highly relevant, issue in biology and pathobiol-
ogy. Glycolytic performance is connected to enzymes abundance, cell fermentative activity and prolifer-
ation, all hallmarks of the ‘Warburg effect’. Both Saccharomyces cerevisiae and mammalian cells can
sense glycolytic state/ﬂux intracellularly, a dominant signal over that of external nutritional status [1–
4]. In S. cerevisiae under favorable growth conditions, high glycolytic activity elicits rapid cell growth,
due to the robust synthesis of proteins and biomass expansion [5–7]. Nutrient-limited growth, on the
other hand, is associated with a down-regulation of transcription and protein synthesis to reduce
demands on the ribosomal machinery and an appropriate supply of amino acids and tRNAs.
As key players in protein synthesis, transfer RNAs are synthesized by RNA polymerase III (RNAP
III), which is also responsible for the transcription of other speciﬁc products such as ribosomal 5S
rRNA and spliceosomal U6 snRNA. RNAP III activity is regulated by extracellular glucose levels [8,9].
The only known direct regulatory factor of RNAP III in S. cerevisiae is the protein Maf1, a mediator
of a range of stress signals [10–13] conserved from yeast to human [14]. Yeast Maf1 inhibits RNAP
III activity reversibly under carbon source starvation and oxidative stress, reducing tRNA transcript
levels [15]. Although the MAF1 gene is not essential for yeast viability, maf1Δ cells are unable to
repress RNAP III [15–18].
Under favorable growth conditions, Maf1 is an interaction partner of several cytoplasmic proteins
playing different biological functions (Figure 1A,B), but its function in the cytoplasm is unknown.
Maf1 is a target of several kinases and phosphorylation patterns may dictate cellular localization
[15,41–47] (Figure 1B).
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Figure 1. RNAP III regulation by Maf1 and Maf1 interaction network.
(A) RNAP III transcription repression is regulated by Maf1. Phosphorylation and dephosphorylation events are involved in the
mobility and transportation of Maf1 through the nuclear membrane in which a group of protein kinases are involved in the
control of Maf1 nuclear localization responding to stress events. Maf1 produces transcriptional repression on RNAP III by
inducing conformational changes. (B) Maf1 protein–protein interaction network. Experimental interactions from STRING
database are shown. Nodes have been colored by protein activity in which different protein complexes related to tRNA
modiﬁcation and transportation can be observed. green: transcription regulation; MAF1: negative regulator of RNAP III, SUB1:
Sub1 transcriptional regulator facilitating elongation through factors that modify RNAP II, role in hyper-osmotic stress response
through RANP II and RNAP III, negatively regulates sporulation [19–21], NOP1: Nop1, histone glutamine methyltransferase,
modiﬁes H2A at Q105 in nucleolus that regulates transcription from the RNAP I promoter involved in C/D snoRNA 30-end
processing. Essential gene leads to reduced levels of pre-rRNA species and defects in small ribosomal subunits biogenesis
[22–24], SUA7: transcriptional factor TFIIB, a general transcription factor required for transcription initiation and start site
selection by RNAP II [25,26] — Sub1 interaction with TFIIB [27]. Marine blue: RNAP III holoenzyme subunits, red: protein
kinases, KOG1: Kog1 the component of the TPR complex, Kog1 depletion display the starvation-like phenotypes — cell
growth arrest, reduction in protein synthesis, glycogen accumulation, up-regulation in the transcription of nitrogen catabolite
repressed and retrograde responses genes conserved in from yeast to man is the homolog of the mammalian TORC1
regulatory protein RAPTOR/mKOG1 [28,29], TOR1 mediates cell growth in response to nutrient availability and cellular stress
by regulating protein synthesis, ribosome biogenesis, autophagy, transcription activation cell cycle [30,31] . Yellow: PKA kinase
inhibitor protein BCY1, pink: tRNA modiﬁcation TAN1: tRNA modifying proteins Tan1 (responsible for tRNASER turnover [32]),
TRM1: Trm1 tRNA methyltranspherase produces modiﬁed base N2, n2 dimethylguanosine in tRNA in nucleus and
mitochondrion [33], PUS1: PUS1 associated with human disease [34], introduces pseudouridines in tRNA, also as on U2
snRNA and pseudouridylation of some mRNA [35,36]. Blue: RPC40 (AC40) is a common subunit to RNAP I and III conserve in
all eukaryotes [37,38]. Light blue: RPO21: largest subunit of RNAP II, which produces all nuclear mRNAs, most snoRNAs and
snRNA and the telomerase RNA encoded by TLC1 [39,40] (according to Saccharomyces Genome Database).
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Growth-limiting conditions result in dephosphorylation of Maf1 by the PP2A and PP4 phosphatases [15,48].
Under unfavorable growth conditions, dephosphorylated Maf1 protein is imported to the nucleus in a process
driven by nuclear localization sequences (NLS) [15,42]. In the nucleus, Maf1 binds to the RNAP III complex
after transcription initiation (for review, see Boguta [49]). Such interaction results in RNAP III dissociation
from tRNA promoter sequences [14,15,43]. On the other hand, favorable growth conditions induce Maf1
inactivation as a repressor by multiple phosphorylation due to casein kinase II (CK2), protein kinase A (PKA),
Sch9 and TOR following speciﬁc stress signals, which affects adversely the binding of Maf1 to RNAP III
[47,50]. In favorable growth conditions, Maf1 is localized predominantly in the cytoplasm, although is never
fully excluded from the nucleus [51].
Although MAF1 deletion is not lethal under optimal growth conditions, deletion mutants display high tRNA
transcription with diminished growth on non-fermenting carbon sources at 30°C; it becomes lethal, however, at
elevated temperatures. The low growth rate results from a decrease in steady-state mRNA levels of FBP1 and
PCK1 genes encoding the key gluconeogenesis enzymes fructose 1,6-bisphosphatase (Fbp1) and phosphoenol-
pyruvate carboxykinase (Pck1) [10,52]. Intriguingly, this maf1Δ growth defect on non-fermentable carbon
sources is suppressed by point mutation (rpc128-1007) in the second largest RNAP III subunit RET1/C128 [13].
tRNA transcription levels in this rpc128-1007 mutant are very low, which suggests that the temperature-sensitive
lethality of maf1Δ can be rescued by attendant reduction in RNAP III activity, or a critical process affected by
this transcription. The maf1Δ and rpc128-1007 strains have different phenotypes, not only in growth on non-
fermentable carbon sources but also in preference towards glucose utilization, in excess glucose [13,53].
Transcription of the high-afﬁnity glucose transporter genes HXT6, HXT7 is decreased in maf1Δ, but increased
over WT in the maf1Δ second-site suppressor rpc128-1007 [53], suggesting differences in glucose utilization.
We wished to explore the potential for a feedback loop between control of glycolytic ﬂux and RNAP III in
yeast cells by label-free proteomics, which revealed changes in abundance of a large group of proteins in maf1Δ
and rpc128-1007 strains, supported with targeted analysis of speciﬁc metabolites. We provide novel molecular data
which is able to explain the severe reduction in growth rate caused by RNAP III mutation rpc128-1007 through
cellular processes that facilitate efﬁcient glucose metabolism in the MAF1 deletion strain on glucose. Changes in
protein proﬁles impact several metabolic pathways, suggesting differences in cellular metabolic homeostasis in the
mutant strains and providing an alternative explanation for maf1Δ lethality on non-fermentable carbon sources.
Finally, using yeast as a model organism, which is often used for studies of the ‘Warburg effect’, we established
direct metabolic relationship between the capacity of the glycolytic pathway and transcription of non-coding
genes, which can explain why several cancerous cell lines exhibit higher RNAP III activity, creating a new perspec-
tive on glucose ﬂux modiﬁcation via manipulation of the RNAP III holoenzyme as a novel therapeutic strategy.
Materials and methods
Yeast strains and media
The following strains were used: wild-type MB159-4D [54] with unchanged RNAP III activity, the MA159-4D
maf1::URA3 [53] MAF1-deﬁcient mutant with elevated RNAP III activity and MJ15-9C mutant [13] with a
single point mutation in the RET1/C128 RNAP III subunit with reduced polymerase activity. Yeast strains were
cultured in rich medium (YP; 1% yeast extract, 1% peptone) supplemented with either 2% glucose (YPD) or
2% glycerol (YPGly) as a carbon source. Overnight cell cultures were grown in YPD medium. Cells were har-
vested by centrifugation (2000 rpm, RT) and washed twice with fresh, sterile YPD or YPGly medium. Yeast
cells were diluted to D600≈ 0.1 and grown in YPD or YPGly until exponential phase (D600 ≈ 1.0). All yeast cul-
tures were incubated at 30°C with agitation 250 rpm. GCN4-3HA DNA construct for chromosomal C-terminus
fusion was prepared as described previously [53,55]. Hexokinase isoforms (HXK1, HXK2, GLK1) single and
double gene deletions were created by transforming haploid yeast strains with appropriate PCR fragments. For
HXK1 deletion ampliﬁcation of His3MX6 cassette on pFA6-VC155-His3MX6 plasmid DNA was done. DNA
constructs for obtaining HXK2- and GLK1-deﬁcient strains were ampliﬁed on gDNA of BY4741 glk1Δ and
BY4741 hxk2Δ (Euroscarf ). High-efﬁciency yeast transformation using LiAc/SS carrier DNA/PEG method was
used according to Gietz and Schiestl [56]. All yeast strains are listed in Table 1.
Proteomic analysis
Samples (∼15 ml culture medium) — corresponding to 25 × 106 cells as determined in a cell count on hemocytom-
eter were analyzed by global label-free proteomics (four biological replicates per strain). Cells were spun down
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(10 min, 4°C) and the pellets ﬂash frozen in liquid N2 for storage. Cells were resuspended in 50 mM NH4HCO3,
protease inhibitor ROCHE mini complete protease inhibitor. The samples were homogenized with Mini-Beadbeater
24 (Biospec products) using the 200 ml of glass beads (425–600 mm; Sigma–Aldrich) 15 times (3000 hits per min)
with a duration of 30 s each with a 1 min cool down period in between each cycle. The cells were further
centrifuged (10 min, 13 000 rpm, 4°C). 250 ml fresh breaking buffer was added to pellets and cells were washed by
vigorous vortexing. The wash and cell debris were collected as ﬂow through. Each ﬂow through and supernatants
from previous steps were combined. Protein concentration was determined with a Bradford assay [57].
Table 1 Yeast strains used in the study
Strain Genotype Reference/source
MB159-4D MATa SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp [54]
MA159-4D maf1Δ MATa SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp maf1::URA3 [53]
MB159-4D maf1Δ MATa SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp maf1::kanMX6 [54]
MJ15-9C MATa rpc128-1007 SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp [13]
RS159-4D Gcn4-3HA MATa SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp Gcn4-3HA-kanMX6 This study
RS15-9C Gcn4-3HA MATa rpc128-1007 SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp
Gcn4-3HA-kanMX6
This study
RS159-4D maf1Δ
Gcn4-3HA
MATa SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp maf1::URA3
Gcn4-3HA-kanMX6
This study
KR159-4D hxk1Δ MATa SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp hxk1::HIS3MX6 This study
KR159-4D maf1Δ hxk1Δ MATa SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp maf1::URA3 hxk1::
HIS3MX6
This study
KR15-9C hxk1Δ MATa rpc128-1007 SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp hxk1::
HIS3MX6
This study
KR159-4D hxk1Δ hxk2Δ MATa SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp hxk1::HIS3MX6 hxk2::
kanMX4
This study
KR159-4D maf1Δ hxk1Δ
hxk2Δ
MATa SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp maf1::URA3 hxk1::
HIS3MX6 hxk2::kanMX4
This study
KR15-9C hxk1Δ hxk2Δ MATa rpc128-1007 SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp hxk1::
HIS3MX6 hxk2::kanMX4
This study
KR159-4D hxk2Δ MATa SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp hxk2::kanMX4 This study
KR159-4D maf1Δ hxk2Δ MATa SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp maf1::URA3 hxk2::kanMX4 This study
KR15-9C hxk2Δ MATa rpc128-1007 SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp hxk2::kanMX4 This study
KR159-4D hxk1Δ glk1Δ MATa SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp hxk1::HIS3MX6 glk1::
kanMX4
This study
KR159-4D maf1Δ hxk1Δ
glk1Δ
MATa SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp maf1::URA3 hxk1::
HIS3MX6 glk1::kanMX4
This study
KR15-9C hxk1Δ glk1Δ MATa rpc128-1007 SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp hxk1::
HIS3MX6 glk1::kanMX4
This study
RS159-4D glk1Δ MATa SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp glk1::kanMX4 This study
RS159-4D maf1Δ glk1Δ MATa SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp maf1::URA3 glk1::kanMX4 This study
RS15-9C glk1Δ MATa rpc128-1007 SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp glk1::kanMX4 This study
BY4741 hxk2Δ MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 hxk2::kanMX4 Euroscarf
BY4741 glk1Δ MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 glk1::kanMX4 Euroscarf
BY4741 reg1Δ MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 reg1::kanMX4 Euroscarf
MB159-4D [pBM2636] MATa SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp [HXT1::lacZ] This study
MB159-4D maf1Δ
[pBM2636]
MATa SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp maf1::KanMX6 [HXT1::lacZ] This study
MB15-9C [pBM2636] MATa rpc128-1007 SUP11 ura3 leu2-3, 112 ade2-1 lys2-1 trp [HXT1::lacZ] This study
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A volume equivalent to 25 × 106 cells of each homogenate was removed, diluted with 25 mM AMBIC con-
taining 0.05% Rapigest (Waters, Manchester) and shaken (550 rpm, 10 min, 80°C). The samples were then
reduced (addition of 10 ml of 60 mM DTT and incubation at 60°C for 10 min) and alkylated (addition of 10 ml
of 180 mM iodoacetamide and incubation at room temperature for 30 min in the dark). Trypsin (Sigma, Poole,
U.K., proteomics grade) was reconstituted in 50 mM acetic acid to a concentration of 0.2 mg/ml and 10 ml was
added to the sample followed by overnight incubation at 37°C. The digestion was terminated and RapiGest™
removed by acidiﬁcation (1 ml of TFA and incubation at 37°C for 45 min) and centrifugation (15 000×g,
15 min). To check for complete digestion each sample was analyzed pre- and post-acidiﬁcation by SDS–PAGE.
For LC–MS/MS analysis, a 2 ml injection of each digest, corresponding to approximately 25 × 104 cells, was
analyzed using an Ultimate 3000 RSLC™nano system (Thermo Scientiﬁc, Hemel Hempstead) coupled to a
QExactive™ mass spectrometer (Thermo Scientiﬁc). The sample was loaded onto the trapping column
(Thermo Scientiﬁc, PepMap100, C18, 300 mm× 5 mm), using partial loop injection, for 7 min at a ﬂow rate of
4 ml/min with 0.1% (v/v) FA. The sample was resolved on the analytical column (Easy-Spray C18 75 mm×
500 mm 2 mm column) using a gradient of 97% A (99.9% water: 0.1% formic acid) 3% B (99.9% ACN: 0.1%
formic acid) to 60% A: 40% B over 90 min at a ﬂow rate of 300 nL min−1. The data-dependent program used
for data acquisition consisted of a 70 000 resolution full-scan MS scan (AGC set to 1e6 ions with a maximum
ﬁll time of 250 ms) the 10 most abundant peaks were selected for MS/MS using a 17 000 resolution scan (AGC
set to 5e4 ions with a maximum ﬁll time of 250 ms) with an ion selection window of 3 m/z and a normalized
collision energy of 30. To avoid repeated selection of peptides for MS/MS the program used a 30 s dynamic
exclusion window.
Label-free quantiﬁcation
The raw data from the mass spectrometer was then processed using MaxQuant (MQ) software version 1.5.3.30
[58]. Protein identiﬁcation was performed with the built-in Andromeda search engine, searching MS/MS
spectra vs. the S. cerevisiae strain ATCC 204508/S288c downloaded from UniProt (https://www.uniprot.org/
proteomes/UP000002311). The following parameters were used; digest reagent: trypsin, maximum missed clea-
vages: 2, modiﬁcations: protein N-terminal acetylation and methionine oxidation, with a maximum of ﬁve
modiﬁcations per peptide. The false discovery rate (FDR) for accepted peptide-spectrum matches and protein
matches was set to 1%. For protein quantiﬁcation, the ‘match between runs’ options was selected. Label-free
quantiﬁcation was performed with the MaxLFQ algorithm within MaxQuant (MQ), based on razor and unique
peptides. All other MQ parameters were left at default values.
Protein signiﬁcance testing
To determine statistically signiﬁcantly changing proteins with respect to the wild-type strain we used the
MSstats package [59] in the R environment. Protein identities, conditions, biological replicates and intensities
were directly uploaded from the MaxQuant output. Protein ID information was obtained from the
‘proteinGroups.txt’ ﬁle, conditions and biological replicates from the ‘annotation.csv’ ﬁle, and intensities from
the ‘evidence.txt’ ﬁle. Data normalization was performed using the ‘equalizeMedians’ option and summariza-
tion using the Tukey’s median polish option. Following this, a condition comparison was performed using the
‘groupComparison’ option from where the log2 fold changes and adjusted P-values were obtained. Adjusted
P-values are used for statistically signiﬁcance. The adjusted P-values are the P-values adjusted among all the
proteins present in the speciﬁc comparisons using the Benjamini and Hochberg approach.
Functional analysis
Gene ontology enrichment analysis was performed with the online application Panther [60], directly on the
Gene Ontology Consortium webpage (http://pantherdb.org/). The background set consisted of all proteins iden-
tiﬁed in a given MS experiment. Protein changes were mapped to central carbon and amino acid metabolic
pathways following KEGG database [61] guidelines. Maf1 protein–protein interactions were obtained from the
STRING [62] database and clustered with the Cytoscape [63] tool.
Transcription factor target enrichment analysis
For transcription factor (TF) target enrichment analysis, all proteins with an adjusted P-value below 0.05 from
both comparisons (WT — rpc128-1007 and WT — maf1Δ) were uploaded to the GeneCodis tool [64]. Proteins
were classiﬁed according to their positive or negative fold change and the background set consisted of all
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY-NC-ND). 1057
Biochemical Journal (2019) 476 1053–1082
https://doi.org/10.1042/BCJ20180701
proteins identiﬁed in the given MS experiment. All statistical parameters were left as default. Adjusted P-values
were obtained indicating those statistically signiﬁcantly TFs being active according to their known target
proteins.
Western blotting
The total cellular proteins from Gcn4-3HA expressing yeast cells were extracted as described previously [53].
Protein extracts were separated by 12% SDS–PAGE and transferred to nitrocellulose membrane by electrotrans-
fer (1 h, 400 mM, 4°C). For detection of HA-tagged proteins, monoclonal mouse anti-HA (1:3330, Sigma,
H3663) and polyclonal goat anti-mouse antibodies (1:2000, Dako P0447) conjugated with horseradish peroxid-
ase (HRP) were used. For Vma2 protein detection, monoclonal mouse anti-Vma2 antibodies (1:4000, Life
Technologies, A6427) were used.
RNA isolation and real-time PCR quantiﬁcation
RNA isolation and real-time PCR ampliﬁcation were performed as described previously [53]. Isolated RNAs
were examined by SYBR-Green-based real-time PCR. Oligonucleotide sequences of the primers used in real-
time PCR experiment for GCN4 were taken from Cankorur-Cetinkaya et al. [65]. Samples were normalized to
two reference genes — U2 spliceosomal RNA (U2) and small cytosolic RNA (SCR1). Expression levels in WT
strain (MB159-4D) were taken as 1.0. The relative expression (mean ± SD) was calculated for at least three
independent biological replicates. Statistical signiﬁcance of P-values was determined by Student’s t-test.
Enzymatic assays
All yeast strains including transformants carrying pBM2636 plasmid [66] for measurement of β-galactosidase
activity were cultivated in rich medium supplemented with 2% glucose (YPD) or 2% glycerol (YPGly) at 30°C
with agitation of 250 rpm until reached D600 ≈ 1.0. Yeast cultures were harvested at 5000 rpm at 4°C and
washed twice with 10 mM potassium phosphate buffer (pH 7.5). Cells for Hxk, Tdh1-3, Cdc19 and Zwf1 activ-
ity assays were suspended in 100 mM potassium phosphate buffer (pH 7.5), for β-galactosidase in 50 mM
potassium phosphate buffer (pH 7.0), rapidly frozen in liquid nitrogen and stored at −20°C. Samples were
washed twice with sonication buffer (100 mM potassium phosphate buffer (pH 7.5), 2 mM MgCl2) or 50 mM
potassium phosphate buffer (pH 7.0) in the second case and disintegrated with Mini-Beadbeater 24 (Biospec
products) using glass beads (425–600 mm; Sigma–Aldrich). Hexokinase (EC 2.7.1.1) activity was measured
according to Adamczyk et al. [67], glyceraldehyde-3-phosphate dehydrogenase (Tdh1-3, EC 1.2.1.12) according
to van Hoek et al. [68], pyruvate kinase (Cdc19; EC 2.7.1.40) according to Grüning et al. [69], glucose-6-
phosphate dehydrogenase (Zwf1, EC 1.1.1.49) according to Postma et al. [70], β-galactosidase according to
Smale [71], and catalase (EC 1.11.1.6) according to Beers and Sizer [72]. All assays were performed for a
minimum of three independent biological replicates.
Glycogen, trehalose, fructose 1,6-bisphosphate and glutathione measurement
The glycogen and trehalose content was measured in yeast cells, grown in YPD until D600≈ 1.0. Cell prepar-
ation and extraction was as described in Rossouw et al. [73]. Glycogen determination was as described by
Parrou and François [74]. Glucose concentration from glycogen enzymatic breakdown was determined by the
glucose (HK) Assay Kit according to the manufacturer’s protocol (Sigma–Aldrich, GAHK-20). Trehalose
content was measured using Trehalose Assay Kit (Megazyme International Ireland, Wicklow, Ireland) accord-
ing to the manufacturer’s protocol. Fructose 1,6-bisphosphate was measured according to Peeters et al. [4] with
minor modiﬁcations. Oxidized (GSSG), reduced (GSH) and total glutathione (oxidized and reduced) levels
were measured according to Quantiﬁcation kit for oxidized and reduced glutathione (Sigma–Aldrich, 38185) as
stated in manufacturer’s protocol.
Determination of yeast fermentative capacity
Fermentative capacity assays were performed as described by van Hoek et al. [75] with minor changes. The
fermentative capacity can be deﬁned as the speciﬁc maximal production rate of ethanol per gram of biomass
(mmol/g/h) under anaerobic conditions at excess of glucose. Samples corresponding to 60–70 mg dry weight
were harvested by centrifugation at 5000 rpm at 4°C. Cells were washed twice with synthetic medium
CBS-without carbon source (CBS-C) and resuspended in CBS (-C) to make 2% wet weight suspensions.
Analysis was performed in a thermostatted (30°C) vessel. Cells were ﬂushed with N2 gas at a ﬂow rate of
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∼0.6 L/h and glucose was added to a ﬁnal concentration of 10 g/liter. Samples for measurement of ethanol
were collected every 5 min, incubated with 35% (w/v) perchloric acid on ice for 10 min and neutralized with
KOH before centrifugation at 13 000 rpm and stored in −20°C freezer. The ethanol production of each strain
was normalized to the dry weight of the culture. Ethanol and glycerol in supernatants were determined with
enzymatic assays according to the manufacturer (Megazyme International Ireland, Wicklow, Ireland).
Biomass determination
Sample suspensions of 1 ml volume in duplicates were ﬁltered over pre-weighted nitrocellulose ﬁlters (pore
size, 0.45 mm; HAWP04700). After removal of medium, the ﬁlters were washed with demineralized water, dried
in an oven overnight and weighed [75].
Results
Overall proteome proﬁling and changes
We hypothesized that perturbations in RNAP III activity would impact on global expression of the proteome.
The lack of the negative regulator of RNAP III, Maf1, as well as the loss of function due to a point mutation in
the RNAP III RET1/C128 subunit, would be expected to elicit broad changes in the S. cerevisiae proteome. We
aimed to identify proteins, the changed abundance of which, could explain the diminished growth of
rpc128-1007 on glucose and de-repression of HXT2 and HXT6/7 genes that encode high-afﬁnity glucose trans-
porters, when compared with maf1Δ under glucose-rich conditions [53]. We, therefore, performed a systematic
comparative analysis of maf1Δ and rpc128-1007 mutants using label-free proteomics.
Reproducible, deep proteome coverage was obtained (Figure 2A) for maf1Δ and rpc128-1007 mutants grown
under glucose-rich conditions. The proteomics data were of high quality, with replicates clustered together and
there was no systematic difference reﬂecting sample preparation bias (Figure 2). In total, over 2300 protein
groups were identiﬁed and quantiﬁed. As anticipated, there was considerable overlap between the maf1Δ and
rpc128-1007 proteomes (Figure 3). Differential proteome analysis was carried out pairwise in two sets as
follows: ﬁrst: WT vs rpc128-1007 mutant and secondly: WT vs. maf1Δ mutant, resulting in 2294 quantiﬁed pro-
teins common to all strains. A subset of statistically signiﬁcant changes revealed 249 proteins that were
common to both comparisons (with an adjusted P-value < 0.05). This subset of 249 proteins were clustered into
coherent groups (see Materials and methods) that display common Gene Ontology (GO) annotation, consistent
with co-ordinated regulation of relevant biological processes (Figure 3). Some of the groups exhibited parallel
changes in the two strains (Groups 1–4) whereas others highlighted divergent, essentially reciprocal, functions
in the two strain (i.e. Groups 5–6). These unbiased clusters show enrichments for concerted biological func-
tions, embodied by the limited subset of GO term enrichments listed in Figure 3, including elements of amino
acid and monosaccharide/carbohydrate metabolism. In both strains, enzymes of gluconeogenesis and the glyox-
ylate cycle were decreased when compared with the reference strain grown under the same glucose repression
conditions (Group 2). Groups 7 and 9 also show decreased protein abundance with respect to wild type and
are similarly enriched in enzymes from the TCA cycle, purine ribonucleotide biosynthetic pathways, inosine
monophosphate biosynthesis de novo, and also mitochondrial transmembrane transport. In contrast, many of
the enzymes involved in amino acid synthesis de novo were increased in abundance in both maf1Δ and
rpc128-1007 (Groups 1, 3 and 4). The negatively correlated, reciprocally altered groups (Groups 5, 6 and 8)
were consistent with shifts in trehalose biosynthesis, pentose phosphate pathway (PPP) activity, oxidative stress,
oxidation–reduction processes, glycine catabolic processes, replicative cell aging and alcohol production.
Key enzymes of the glyoxylate cycle are reduced in abundance in both maf1Δ
and rpc128-1007 mutants.
In both strains, phosphoenolpyruvate carboxykinase (Pck1) the gluconeogenetic enzyme and malate synthase 1
(Mls1) were reduced (Figure 4). These enzymes direct acetyl-CoA to malate and oxaloacetate that in turn can
be metabolized to phosphoenolpyruvate for gluconeogenesis. Mls1 is a component of the glyoxylate cycle that
allows yeast cells to metabolize non-fermentable carbon sources, including fatty acids. The mechanism govern-
ing glucose-repressed genes is particularly important in the RNAP III compromised mutant as well as in
Maf1-deprived cells due to the previously reported growth perturbations of maf1Δ on non-fermentable carbon
source. Two-fold decrease in maf1Δ PCK1 mRNA was reported [52], though under inducing conditions on gly-
cerol. Notably, the relative decrease in Pck1 abundance in Maf1-deﬁcient cells is the largest in our proteomic
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dataset. The very much decreased Pck1 abundance proves that the enzyme is subject to degradation in a
glucose-dependent manner [76] and the mechanism is not perturbed in both the mutants. Other enzymes of
the glyoxylate cycle are concomitantly reduced in maf1Δ cells, including malate dehydrogenases Mdh2, Mdh3,
isocitrate lyase (Icl1) and glyoxylate aminotransferase (Agx1), the last implicated in glycine synthesis from
glyoxylate. In rpc128-1007, most of the glyoxylate enzymes as well as those of the TCA cycle were also
decreased. To our knowledge the decrease in abundance of TCA cycle enzymes in these mutants does not acti-
vate retrograde signaling, otherwise, we would have observed auxotrophy for glutamate in the mutant strains
(Supplementary Figure S1).
Enzymes of the TCA and glyoxylate cycles undergo co-ordinated transcriptional down-regulation [76,77]
induced by glucose through the master kinase Snf1/AMPK [78,79] therefore strongly suggesting unperturbed
functioning of Snf1 signaling on glucose. In contrast, the other key enzyme of gluconeogenesis, Fbp1 (fructose
1,6-bisphosphatase) that bypasses the physiologically irreversible step in the glycolytic pathway, was increased
under glucose deprivation in maf1Δ, but was unchanged in the rpc128-1007 mutant.
Reduction in glycolytic enzymes in a RNAP III compromised strain correlates
with lower activity of the glucose transporter Hxt1
Proteome analysis captured changes in relative cellular abundances of all glycolytic enzymes and implied a
reduced capacity for glycolysis in rpc128-1007 cells, but an unchanged glycolytic capacity in maf1Δ cells
(Figure 4). In rpc128-1007, enzymes that were signiﬁcantly decreased (between 2- and 2.6-fold) included
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Figure 2. Proteome signature of maf1Δ and rpc128-1007 mutants compared with the wild-type strain.
(A) Histogram of proteins present on both mutants organized according to their corresponding Log2 fold change expression.
(B) Comparative scatter plots and histograms of the different strains. The Log2 transformed protein abundances of proteins
present in the WT, rpc128-1007 and maf1Δ strains are plotted against one another along with their distribution. The number
shown is the Pearson correlation coefﬁcient between the two relevant strains. (C) Principal component analysis (PCA) based on
proteins present on all four biological replicates.
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glyceraldehyde-3-phosphate dehydrogenase isozyme 1 (Tdh1), enolase (Eno1), glyceraldehyde-3-phosphate
dehydrogenase isozyme 2 (Tdh2), 3-phosphoglycerate kinase (Pgk1) and glucokinase (Glk1). The lower abun-
dance of the entire complement of glycolytic enzymes is consistent with reduced glycolytic performance in
rpc128-1007.
Glycolytic ﬂux in S. cerevisiae can regulate glucose uptake, at least in part through the activity of glucose
uptake mechanisms [80] and in particular, induction and increases of membrane internalization of low-afﬁnity
glucose transporters [66,81–84]. The principal example is Hxt1, only activated when yeast grow in glucose-rich
media [66]. We explored the potential for changes in glucose transport by measurement of transcriptional
de-repression of the key gene encoding the major low-afﬁnity, high-capacity glucose transporter HXT1, in
maf1Δ and rpc128-1007 using a HXT1-lacZ reporter plasmid (Figure 5B). The HXT1 gene was strongly acti-
vated in maf1Δ under glucose-rich conditions, whereas a 3-fold lower activity of the HXT1 promoter was
observed in rpc128-1007 cells in the same conditions. When assessed in cells grown on glycerol, expression of
Figure 3. Increased and decreased protein abundance is presented relative to the wild-type strain for both maf1Δ and
rpc128-1007 mutants.
All those statically signiﬁcant proteins with an adjusted P-value < 0.05 overlapped between both comparisons were then
subjected to hierarchical clustering. This clustering analysis created different groups showing the similarities and differences
between both mutants with clusters enriching to biological processes related to amino acid and carbohydrate metabolism,
response to stress, and respiratory processes.
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HXT1-lacZ reporter was decreased in all strains (Figure 5B) as expected [66]. Consistent with the reports on
mutants in genes of the glycolytic pathway, which are blocked in glycolysis [85], the HXT1 expression was
reduced in RNAP III compromised yeast suggesting that in this mutant, the supply of glucose for a functional
glycolytic pathway cannot be maintained.
Positive relationship between Hxk2, Tdh1-3 and Cdc19 enzyme activities and
the potency of RNAP III-dependent transcription
Since HXT1 gene expression was elevated in maf1Δ, but decreased in rpc128-1007, we measured the activity of
selected glycolytic enzymes in vitro [67] in both mutant strains and evaluated the relationship between activity
Figure 4. Comparative proteomic proﬁling of maf1Δ and rpc128-1007 mutants when compared with the wild-type strain.
The differences in protein abundances are presented on a schematic representation of the central carbon metabolism. Those
proteins with an increased abundance are presented in red and those with a decreased abundance in green.
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Figure 5. Opposite effects have been observed in HXT1 promoter activity in strains with altered RNAP III.
(A) Schematic representation of glucose uptake and phosphorylation in yeast cells. Hxt, hexose transporter; P,
phosphorylation; Hxk1, hexokinase 1; Hxk2, hexokinase 2; Glk1, glucokinase 1. WT, maf1Δ, rpc128-1007 yeast cells and
single or double HXK1, HXK2, GLK1 knockouts strains in WT, maf1Δ and rpc128-1007 genetic background were cultured in
YPD (C) or YPGly (D) rich medium under either inducing (2% glucose) or repressing (2% glycerol) conditions. Maf1 deﬁciency
increases HXT1 expression (B) on glucose and Hxk2 activity regardless of carbon source (C, D). Metabolic effects observed
in rpc128-1007 correlate with decreased HXT1 expression (B) and decreased hexokinase activity in glucose-rich medium
(C), but increased hexokinase activity in glycerol rich medium (D). Compromised RNAP III and maf1Δ have an effect on
enzymes in lower glycolysis: Tdh1-3 and Cdc19 activities (E, F). The WT strain (MB159-4D), maf1Δ and rpc128-1007 mutant
strains were grown under 2% glucose and 2% glycerol conditions. The experiment was performed in cell-free extracts
isolated from the aforementioned strains. Data are expressed as the mean obtained from at least three independent
experiments measured in triplicate. The standard deviations are shown. Enzymatic assays were performed in cell-free
extracts. The reaction rates were monitored by measuring NADH concentration change over time at 340 nm. Vmax mean value
is expressed as mmol·min−1·mg−1 protein (C, D, E, F). (B) HXT1 expression was measured in WT [pBM2636], maf1Δ
[pBM2636] and rpc128-1007 [pBM2636] strains by using the lacZ reporter gene system [66]. β-galactosidase activity was
assayed in cell-free extracts. The error bars indicate the standard deviation from three independent transformants assayed in
triplicate. Asterisk (*) indicate P-value <0.05 and double asterisk (**) illustrate P-values <0.1 according to Student’s t-test
averaged from all technical repeats.
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changes and changes in protein abundance assessed by proteomics. S. cerevisiae encodes three isoenzymes with
hexokinase activity (Figure 5A). Proteomic analysis showed that Glk1 was the only isoenzyme phosphorylating
glucose in maf1Δ (Figure 4), with increased abundance whereas Hxk1 and Hxk2 were observed decreased in
this strain. For rpc128-1007, the protein abundance of all enzymes conferring hexokinase activity was decreased
(Figure 4). We, therefore, grew the three strains in rich media supplemented with 2% (w/v) glucose and mea-
sured the hexokinase reaction (Vmax) in cell-free extracts. Total hexokinase activity was increased in maf1Δ and
reduced in rpc128-1007 (Figure 5C, solid bars).
To quantify the activities of the individual hexokinase enzymes we designed and constructed deletion
mutants of hexokinases in the three strains (Figure 5C,D). Quantiﬁcation of glucose phosphorylation activity in
single and double null mutants of genes encoding hexokinases clariﬁes that hexokinase 2 (Hxk2) is the pre-
dominant isoenzyme engaged in glucose phosphorylation in maf1Δ. The triple deletion maf1Δ hxk1Δ glk1Δ, in
which the only isoform left intact is Hxk2, results in comparable hexokinase activity to the observed in maf1Δ
deletion strain with all the isoforms present (Figure 5C). In contrast, the mutants in whom we observe the
reverse trend in the enzymatic activity are the maf1Δ hxk2Δ double mutant and maf1Δ hxk1Δ hxk2Δ triple
mutant. An increase in glycolytic ﬂux is possible to achieve in cells lacking Maf1 despite a decrease in Hxk2
abundance and only a slight increase in Glk1 cellular concentration. Under growth on glycerol, there was an
increased contribution of Hxk1 to total hexokinase activity in wild-type maf1Δ and rpc128-1007 (Figure 5D),
suggesting that the compensation regulatory mechanisms are not perturbed in the two mutant strains. HXK1
induction by non-fermentable carbon source has previously been reported [86]. Interestingly, on glycerol
growth, the total hexokinase activity in rpc128-1007 was higher than in maf1Δ.
Since glyceraldehyde-3-phosphate dehydrogenase (Tdh1-3) and pyruvate kinase (Cdc19) are important pro-
viders of NADH and ATP respectively, these enzymes were also assayed. Measuring the activity of controlling
and rate-limiting glycolytic enzymes is one of the techniques to estimate carbon ﬂux through the entire
pathway. In yeast, glyceraldehyde-3-phosphate dehydrogenase, placed between upper and lower segments of
glycolysis, is considered a rate controlling step of glycolysis [87,88], whereas Cdc19 kinase levels affect the rate
of carbon ﬂux and its direction towards pyruvate (PYR) or phosphoenolpyruvate (PEP) under fermentative
conditions. The activity of Cdc19 is sufﬁcient to cause a shift from fermentative to oxidative metabolism in S.
cerevisiae [69,89] and controls glycolytic rate during growth on glucose [90].
In maf1Δ, in which there was a small increase in Tdh1, 2 abundance (Tdh1; 0.21 log2FC and 0.3 adjusted
P-value, Tdh2: 0.16 log2FC and 0.37 adjusted P-value), in vitro activity was 2-fold higher (Figure 5E). From
proteomics, Tdh1-3 activity was slightly lower in rpc128-1007 cells under the same growth conditions, but
Tdh1-3 activity measured in rpc128-1007 grown on glycerol was signiﬁcantly lower when compared with the
reference strain, which suggests that the catalytic activity of the enzyme decreases in vivo while the enzyme con-
verts 1,3-bisphosphoglycerate (1,3-BPG) into glyceraldehydes-3-phosphate (G3P) in the reverse direction to
glycolysis, when the enzymes are involved in gluconeogenesis in the presence of non-fermentable carbon
sources in the medium. This shuttle between the cytosol and the nucleus linking metabolic redox status to gene
transcription [91] and contributes to tRNA transport [92].
We further measured the activity of the ﬁnal enzyme in the glycolytic pathway, pyruvate kinase (Cdc19)
activity. Cdc19 protein abundance is comparable in maf1Δ and its parental strain. We found (Figure 5F), that
Cdc19 shows signiﬁcantly lower enzymatic activity in rpc128-1007 compared with the reference strain grown
on glucose, but a slightly elevated activity in Maf1-deﬁcient cells both on glucose and glycerol. Overall, in
maf1Δ the glycolytic enzymes show higher activity than originally thought judging by proteomics data, whereas
Hxk2, Tdh1-3 and Cdc19 protein decreased abundance in rpc128-1007 is fully in agreement with their reduced
enzymatic activity. This leads us to the conclusion that glycolytic ﬂux is diminished in rpc128-1007, whereas in
maf1Δ it is not only higher than in rpc128-1007 but also than in WT. Due to the fact that F16BP mediated allo-
steric control [93–95], but not Cdc19 abundance or phosphorylation, was reported as having a predominant
role in regulating the metabolic ﬂux through the pyruvate kinase Cdc19 [96], we decided to measure F16BP
intracellular concentration.
Fructose 1,6-bisphosphate intracellular concentration does not reﬂect
differences in RNAP III activity and glycolytic ﬂux in the mutant strains
The glycolytic metabolite F16BP is a molecule triggering of the metabolic switch from respiration to fermenta-
tion in unicellular and higher organisms [3,4,90]. We reasoned that lower glycolytic ﬂux in rpc128-1007 would
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result in lower fructose 1,6-bisphosphate (F16BP) concentration in this mutant. We measured F16BP in
rpc128-1007 grown under anaerobic conditions. After the addition of 100 mM glucose, F16BP concentration
sharply increased during the ﬁrst two minutes to the physiological level observed in the wild-type cells but then
declines to a new steady state. In maf1Δ cells, the concentration of F16BP is similar to rpc128-1007 but there is
no initial overshoot (Figure 6). The intracellular level of F16BP is therefore unlikely to be the trigger for the
perturbed metabolic switching in cells with different RNAP III activity. Another product of glycolysis (or its
side branches) may control the transcriptional reprogramming in yeast, particularly when there are
multiple-metabolite-responsive elements present at promoters to sense diverse metabolic signals. Additionally,
F16BP concentration may affect Cdc19 activity in vivo, and thus, the ﬂux direction.
Higher glucose ﬂux in Maf1-deﬁcient cells results in activation of glycogen
and trehalose shunts
We explored the direction of carbon ﬂux in maf1Δ in the absence of any increase in F16BP concentration.
Yeast cells are equipped to counteract excessive inﬂux of glucose by the diversion of glucose into glycogen and
trehalose [97]. During exponential growth, glycogen and trehalose biosynthesis play additional roles as part of
an adaptive response facilitating survival when the cell is challenged with increased glycolytic ﬂux as a conse-
quence of glucose overﬂux into a cell. The glycogen shunt prevents accumulation of glycolytic intermediates,
particularly F16BP and ATP that otherwise would ultimately lead to perturbation in cell metabolic homeostasis
[98–101].
The proteomics data conﬁrmed a strong, negative correlation between RNAP III activity and enzyme abun-
dance in the trehalose and glycogen synthesis pathways, which share common enzymes. UDP-glucose pyropho-
sphorylase (Ugp1), trehalose-6-P synthases (Tps1 and Tps2) and glycogen synthase (Gsy2) increase in maf1Δ,
whilst the same proteins were markedly reduced in rpc128-1007 cells (Figure 3, group 6; Figure 4). The product
of Tps1 activity, trehalose-6-phosphate, controls glycolysis by restricting the ﬂow of glucose into the pathway
and is an allosteric inhibitor of hexokinase 2 activity [98,102]. We assessed the metabolic allocation of glucose
Figure 6. Changes in intracellular concentration of fructose 1,6-bisphosphate (F16BP).
Intracellular fructose 1,6-bisphosphate concentration is lowered in cells with changed RNAP III activity under glucose pulse
experiment. Cells were grown in YPD until reaching D600≈ 1.0, collected washed in minimal medium lacking carbon source
(CBS-C) and resuspended in CBS (-C). Analysis was performed in a thermostatted vessel at 30°C. Cells were ﬂushed with Ar2
gas and glucose was added to a ﬁnal concentration of 2%. Cell samples suspension were collected in time. Fructose
1,6-bisphosphate content was measured by enzymatic breakdown of NADH monitored by changed absorbance at 340 nm in
time according to [4]. Fructose 1,6-biphosphate concentration was calculated from a standard curve and standardized to cells
dry weight expressed in g. Results are shown as mean value for four biological replicates.
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through quantiﬁcation of trehalose and glycogen content during exponential growth. Both metabolites were
2.5-fold higher in maf1Δ in the presence of high glucose. In contrast, rpc128-1007 cells could accumulate
neither glycogen nor trehalose (Figure 7A,B).
In summary, the results are consistent with increased glycolytic ﬂux in maf1Δ and conversely, a diminished
ﬂux in rpc128-1007. Metabolic overﬂow in maf1Δ leads to ﬂux redistribution into the trehalose pathway, to
protect the cells from either an increase in intracellular glucose concentration or accumulation of glycolytic
intermediates downstream from glucose-6-phosphate as observed in wild-type budding yeast [103].
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Figure 7. Maf1-deﬁcient yeast strain accumulates glycogen (A) and trehalose (B) during the exponential phase.
Yeasts were cultivated in rich medium supplemented with 2% glucose and harvested by centrifugation at D600≈ 1.0. Glucose
concentration from enzymatic breakdown of glycogen (A) by amyloglucosidase from A. niger, was determined by the Glucose
(HK) Assay Kit (GAHK-20, Sigma). Trehalose (B) content determination assay was performed using Trehalose Assay Kit
(Megazyme International Ireland, Wicklow, Ireland) according to the manufacturer’s protocol. Trehalose and glycogen content is
presented as a mean value of at least three independent biological replicates with standard deviations. There were no
signiﬁcant changes in the ethanol production rate between wild-type (MB159-4D) and maf1Δ strain (C). maf1Δ accumulated
glycerol (D). Ethanol and glycerol concentration was determined under Fermentative capacity assay (FCA) conditions in maf1Δ
strain (C and D). Fermentative capacity assay was performed as described by van Hoek et al. [75] with modiﬁcations (for
details, see Materials and methods section). All assays were performed in triplicates. Results are shown as mean concentration
(g/L) value with the standard deviation in time (min). ‘C-limited’ stands for ‘carbon-limited conditions’. Asterisk (*) indicate
P-value <0.05 and double asterisk (**) illustrate P-values <0.1 according to Student’s t-test calculated from biological
replicates.
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Ethanol overproduction is not observed in cells lacking Maf1 during
logarithmic growth
In yeast, glucose is fermented to ethanol for energy production, as it is often used as a measure of increased
glycolytic ﬂux. We examined, whether maf1Δ produces ethanol more efﬁciently than the wild type, as might be
predicted from the Group 8 GO terms (Figure 2). Pyruvate decarboxylases isoenzymes Pdc5 and Pdc6 (the key
enzymes in alcohol fermentation) are increased in abundance in maf1Δ (1.7 and 2.3 Log2FC, respectively), sug-
gested that Maf1 deﬁciency should lead to increased ethanol synthesis. We performed a fermentative capacity
assay under anaerobic conditions; without cells pretreatment or with the pretreatment, when cells were glucose
starved for 10 min. Under both condition, there was no evidence of enhanced ethanol production in maf1Δ
(Figure 7C, Supplementary Table S1). Instead, accumulation of the fermentation by-product, glycerol was
observed (Figure 7D). This is consistent with increased glycolytic ﬂux being rerouted upstream of pyruvate or
downstream from acetaldehyde by the enzymes of the pyruvate dehydrogenase bypass [75].
Glycerol rather than ethanol production was also evident under aerobic conditions suggesting that access to
oxygen does not affect the glycolytic ﬂux redirection towards glycerol biosynthetic pathway in maf1Δ. The
maf1Δ mutant is possibly under oxidative stress since glycerol production has a role in response to the stress.
Evidence for oxidative stress in maf1Δ also derives from increased protein abundance for the pentose phosphate
pathway (PPP) enzymes in this mutant, which balances the systemic manifestation of reactive oxygen species
and the ability to detoxify reactive intermediates [104].
Activation of pentose phosphate pathway in cells deprived of Maf1 regulator
The comparative proteomic analysis suggests reciprocal modulation of the pentose phosphate pathway (PPP),
in rpc128-1007 and maf1Δ (Figures 4 and 9). PPP is a source of NADPH during oxidative stress conditions.
The data are consistent with an increase in ﬂux through the PPP in maf1Δ, which can be achieved by increased
glucose-6-phosphate dehydrogenase Zwf1 abundance, the enzyme catalyzing the rate-limiting, irreversible step
of the pathway. Downstream enzymes including 6-phosphogluconolactonase (Sol3, Sol4) and 6-
phosphogluconate dehydrogenase Gnd2 that balance the redox potential via the cytosolic NADPH/NADP+
ratio in native yeast cells and both isoforms of transketolase (Tkl1, Tkl2) are increased in maf1Δ. Conversely,
depletion of Zwf1, Sol4, Tkl1 and Tkl2 in rpc128-1007 is consistent with a reduced potential of this mutant to
redirect carbon ﬂux from glucose-6-phosphate (G6P) towards 6-phosphogluconolactone (6PG) and down-
stream metabolic intermediates (Figures 4 and 9).
We grew yeast in rich medium supplemented with 2% glucose as previously and measured the Zwf1
glucose-6-phosphate dehydrogenase reaction rates (Vmax) in cell-free extracts to check the potential to produce
NADPH. This enzyme is highly regulated and is critical in determining the overall ﬂow of glucose into the
pentose phosphate pathway [105,106]. Zwf1 activity in maf1Δ, was elevated not only on glucose, as a carbon
source, but also on glycerol whereas the enzyme activity in rpc128-1007 remains essentially unchanged
(Figure 8A). To further corroborate the relationship between MAF1 deletion and the oxidative stress response
other proteins, such as Ctt1 stress inducible cytosolic catalase T were elevated (Supplementary Table S2).
Furthermore, total catalase activity was higher in maf1Δ, when compared with WT or rpc128-1007 (Figure 8B).
The magnitude of the abundance changes in enzymes of the oxidative stress response is usually observed
during carbon source downshift. Here, however, it occurs in the presence of glucose during the exponential
phase, indicates that MAF1 gene deletion elicits broader metabolic reprogramming than originally thought and
may present a particular case of a cell’s steady-state with high capacity of antioxidant defense.
Additionally, we measured the ratio of oxidized/reduced glutathione in both mutant strains (Figure 8C) and
observed no increase in GSSG/GSH ratio, but a higher overall concentration of the total glutathione in
rpc128-1007. This suggests that maf1Δ is protected efﬁciently from oxidative stress by the reactive oxygen
species (ROS) scavenging enzymatic cytoprotective system (Supplementary Table S2) whereas rpc128-1007 may
predominantly use the back-up chemical system (GSSG/GSH) to control redox state and to reprogram metabol-
ism in order to efﬁciently maintain the redox homeostasis. The increased levels of total glutathione
(γ-glutamyl-L-cysteinyl-glycine) in rpc128-1007 may indicate changes in turnover proﬁle of this compound, that
consist of glutamic acid, cysteine and glycine; from which the ﬁrst and the latter are precursors in purine
nucleotides biosynthesis. The increased level of glutathione has been previously observed under dietary restric-
tion in rodents [107,108]. It is not entirely clear how nutrients limitation such as glucose contribute to this
effect.
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RNAP III subunit RET1/C128 point mutation is associated with metabolic
reprogramming dependent on transcriptional and translational induction by Gcn4
Glycolytic intermediates are precursors of the carbon skeletons of several amino acids. Thus, lowered glucose
ﬂux could result in the amino acid starvation response in yeast. We identiﬁed a large group of proteins that
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Figure 8. Zwf1 and the Ctt1 catalase activity is increased in Maf1-deﬁcient mutant.
Yeast cells logarithmically growing in YPD (A, B, C) or YPGly (A) medium were harvested at D600≈ 1.0. (A) For Zwf1 activity
assay, NADH breakdown was measured at 340 nm in time at 30°C. For catalase activity (B), hydrogen peroxide decomposition
in reaction mixtures containing yeast cell-free extracts was monitored as a change in absorbance at 240 nm in time at 30°C.
Results are presented as total mean enzymatic activity from ﬁve independent biological replicates with standard deviation
expressed as mmol·min−1·mg−1 protein. Asterisk (*) indicate P-value <0.05 according to Student’s t-test for biological replicates.
(C) Glutathione GSSG/GSH ratio in maf1Δ and rpc128-1007 does not indicate oxidative stress. GSSG, GSH and total
glutathione levels were measured according to Quantiﬁcation kit for oxidized and reduced glutathione (Sigma–Aldrich, 38185)
from the kinetic method in agreement with the manufacturer’s protocol. Yeast strains were grown in rich medium supplemented
with 2% glucose until D600≈ 1.0. The absorbance was obtained for four biological samples assayed in duplicate at 405 nm.
[GSSG]/[GSH] ratio was measured separately for each sample and averaged. Results are shown as a mean value with standard
deviation from four biological replicates. Asterisk (*) indicate P-value <0.05 according to Student’s t-test for biological replicates.
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were substantially increased in abundance, that are involved in amino acid biosynthesis. The relative abundance
of those was increased in rpc128-1007 relative to WT. However, the same set of enzymes in maf1Δ were
increased in some cases and unchanged in others. The magnitude of the increases was generally much higher
in the rpc128-1007 compared with the maf1Δ mutant. In rpc128-1007, over 30 proteins in the pathways for
arginine, lysine, leucine, isoleucine, and valine biosynthesis de novo, along with aromatic amino acids such as
histidine, tryptophan, tyrosine and threonine or their precursors were elevated (Figure 9).
In rpc128-1007, the decreased cellular concentration was observed in methionine biosynthesis subpathway,
that is for ATP sulfurylase the product of MET3 gene essential to catalyze the ﬁrst step for assimilatory reduc-
tion in sulfate to sulﬁde, involved in methionine metabolism. The other proteins diminished in rpc128-1007
were Ser3, Ser33, Cys3 and Shm2 contributing to serine and cysteine biosynthesis.
In maf1Δ, the proteins Arg4, Arg3, Cpa2, Bat1, Bat2, Leu1, Leu4, Leu9 and Ilv3 were elevated; all are compo-
nents of the metabolic branch that is part of L-arginine and L-leucine biosynthesis (Figure 9). In contrast
rpc128-1007, maf1Δ cells exhibited enrichment in the branch of serine/cysteine, methionine biosynthesis
pathway and sulfate metabolism (Met3, Met5, Met10, Met14), and these abundance changes were amongst the
Figure 9. Amino acid biosynthesis and associated proteome signature.
Abundance protein patterns for amino acid metabolism are presented showing those proteins with an increased abundance in
red and those with a decreased abundance in green.
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY-NC-ND). 1069
Biochemical Journal (2019) 476 1053–1082
https://doi.org/10.1042/BCJ20180701
largest in the proteomic dataset. The expression of most genes involved in amino acid biosynthesis is under the
control of the major Gcn4 transcriptional activator, part of the general amino acids control (GAAC) regulon
[28,109]. GCN4 transcription is stimulated by starvation for amino acids, purine, glucose limitation and specif-
ically by initiator tRNAMet depletion [110,111]. Therefore, we evaluated the mRNA levels of GCN4 by RT-PCR
(Figure 10A).
The GCN4 mRNA steady-state levels were 11-fold higher in the rpc128-1007 and, 2-fold elevated in maf1Δ
compared with WT cells. The difference between these two mutants is reﬂected in the extent of the response in
the proteomics analysis rpc128-1007 had much stronger phenotypic change than maf1Δ. We constructed
mutant strains with chromosomally encoded GCN4-3HA protein fusions to assess Gcn4 protein abundance by
immunoblotting. Gcn4 abundance, normalized to Vma2 level in the total protein extracts, was elevated 3-fold
in rpc128-1007 and 2-fold in maf1Δ, when compared with the reference strain (Figure 10B,C). The marked
decoupling between transcript and protein changes in the strains, rpc128-1007 (11-fold mRNA, 3-fold protein)
and maf1Δ (2-fold mRNA, 2-fold protein), also suggests that other regulatory factors are in operation.
For the entire proteome data set, we were able to perform transcription factor enrichment analysis, using the
web-based GeneCodis tool to identify over-representation of the targets of given transcription factors in the dif-
ferentially abundant proteomes (Figure 11). For rpc128-1007, Gcn4 has the most signiﬁcant enrichment of its
targets genes in the proteins which increase in abundance shown by the red line. The second most signiﬁcant
transcription factor in gene activation relationship was observed for Leu3 (Supplementary Figure S2) followed
by Yap1 and Bas1. We also identiﬁed a group of genes with motifs enriched for GATA transcriptional factors
such as Dal81, Dal80 and Gzf3 regulating genes by nitrogen catabolite repression (NCR). The increase in Gcn4
A
B
C
Figure 10. GCN4 transcripts and Gcn4 protein relative levels are signiﬁcantly increased rpc128-1007 yeast cells and
moderately in maf1Δ cells.
Yeast cells were grown in rich medium supplemented with 2% glucose until reached exponential growth phase (D600≈ 1.0).
SYBR-Green-based real-time PCR (A) showed that GCN4 transcript increased 2-fold in maf1Δ and by 11-fold in rpc128-1007.
Wild-type strain expression level was taken as 1.0. Samples were normalized to two reference genes — U2 spliceosomal RNA
(U2) and small cytosolic RNA (SCR1). Asterisk (*) indicates P-values lowered than 0.05 according to Student’s t-test using all
technical replicates of biological samples. Western blotting assay (B) showed increased stability of Gcn4-3HA protein in maf1Δ
and rpc128-1007 mutant strains expressing chromosomally encoded Gcn4-3HA. Total cell protein extracts were subjected to
SDS–PAGE and examined by Western blotting with anti-HA antibodies (B). Quantitative relative level of Gcn4-3HA protein in
comparison with yeast Vma2 protein level was calculated for at least three independent biological replicates (C).
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Figure 11. Transcription factor enrichment analysis.
Enrichment in the proteome sets for individual transcription factors was calculated using the GeneCodis website taking the
sets of proteins with an adjusted P-value of <0.05 from both strains maf1Δ and rpc128-1007 compared against the wild-type.
Proteins were classiﬁed according to their positive or negative fold change and the background set consisted of all proteins
identiﬁed in the given MS experiment.
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levels we observed may contribute to activation of some of the NCR sensitive genes alone or in concert with
Gln3 (FT gene regulator in response to nitrogen limitation or starvation). Some genes possess both Gcn4 and
Gln3 binding sites in their promoter [112]. As these transcriptional factors were represented by a much smaller
group of up-regulated genes and the yeast cells were grown in the rich medium it seems that these genes
up-regulation is not the result of increased NCR activity. We also note that RPN4, the FT of genes encoding
protein degradation machinery, including the 26S proteasome genes [113], is most signiﬁcant in the down-
regulated targets in rpc128-1007 (Supplementary Table S3).
The outcome of experimental and in silico analyses is that the dramatic increase in speciﬁc protein changes
observed in rpc128-1007 can be largely attributed to the GCN4 stress response to low glucose ﬂux and GCN4
de-repression on glucose as a compensatory effect. By contrast with the highly focused changes in rpc128-1007,
the gene regulatory network in maf1Δ (which liberates RNAP III from regulatory circuits and nutrient signal-
ing) (Figure 1), exhibits a broad spectrum of modest changes (including more balanced GCN4 up-regulation)
across several cellular processes, to provide the mutant with better adaptation/selective advantage to growth in
glucose-rich environment.
Discussion
Regulation of the central carbon metabolism of S. cerevisiae has always been a topic of considerable interest.
Here, we present for the ﬁrst time, the evidence that glycolytic ﬂux in yeast can be modulated accordingly to
the RNAP III activity and that central carbon metabolism adjusts to the activity of RNAP III in yeast. Our
results clearly indicate the new connections between RNAP III and cellular metabolism. On the basis of the
previous and the present ﬁndings, we propose that there is internal signaling in the yeast cells that competes
with the extracellular nutrients-sensing, when a cell faces non-optimal RNAP III activity.
A RNAP III point mutation in the RET1/C128 subunit is correlated with lower
efﬁciency of glycolysis and up-regulation of GCN4-dependent genes of
amino acid metabolism
In a previous report, we have shown that the rpc128-1007 strain is insensitive to external glucose concentration
cues, which manifests via constitutive overexpression of the HXT2 gene, whether in glucose or glycerol growth
conditions [53]. Our new data suggest that the rpc128-1007 mutant operates under substrate limitation, such as
glucose, even though the sugar is present in excess in the growth medium. RNAP III activity inhibition results
in diminished abundance of enzymes in central carbon metabolism and elicits preferential accumulation of pro-
teins involved in amino acid biosynthesis (Figure 9) attributable to the GCN4 response. The molecular events
that induce Gcn4 translation also reduce the rate of general protein synthesis [109]. Gcn4 is translationally
up-regulated in response to numerous tRNA perturbations [111,114] and yeast cells with the RET1/C128 point
mutation produce as much as 1.6-fold less tRNA molecules compared with WT [13]. This suppresses the
defect of Maf1 inactivation, caused by increased or unbalanced levels of various tRNAs including increased
tRNAMet levels [13]. Initiator tRNAMet depletion triggers a GCN4-dependent reprogramming of global genome
expression in response to decreased RNAP III transcription in rpc160-112 mutant (in the largest C160 subunit)
[111]. However, HXT2 transcription is not dependent on Gcn4 transcriptional activity [111] in the rpc160-122
mutant. HXT2 overexpression in rpc128-1007 is most likely related to lower glycolytic efﬁciency in the mutant
strain [85], but the direct regulator of the phenomenon still remains to be discovered.
The biological signiﬁcance of the increase in enzymes abundance in amino acids biosynthesis pathways, let
us speculate that in rpc128-1007 de novo synthesized amino acids provide an alternative source of metabolic
intermediates to other processes. It is possible that these mutant cells reprogram their metabolism in order to
guarantee that there are sufﬁcient biosynthetic precursors for replication. This is indicated in Figure 3, group 6
in which some genes involved in replicative aging are not abundant. De novo synthesis of nucleotides occurs
from readily available components such as glutamine, aspartate (indicated in Figure 3 group 1 with genes
involved in aspartate biosynthesis are strongly represented) and glycine (indicated in Figure 3 group 5 genes in
glycine catabolic processes are strongly represented). Further in de novo IMP synthesis, the ﬁrst nucleotide
formed that is further converted to AMP or GMP (indicated in Figure 3 group 9, in which gene involved in
synthesis are drastically decreased by log2FC-5), relies not only on availability of amino acids but also compo-
nents of the folate-one-carbon pool (10-formyl THF) and ribose 5-P derived from glucose in PPP pathway.
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In the wild-type yeast cells, most glycolytic enzymes exist with signiﬁcant overcapacity, regardless of the carbon
source. The enzymes are present in the cells at generally ﬁxed concentration, even if reverse glycolytic processes
take place [115]. However, in the rpc128-1007 mutant, the abundance of all the glycolytic isoenzymes is reduced
and concomitantly with a decrease in abundance of several proteins engaged in the side branches of the glycolytic
pathway (trehalose/glycogen shunt and PP pathway). The two enzymes, fructose 1,6-bisphosphatase Fbp1 and
pyruvate kinase 2 Pyk2, that catalyze the reactions in gluconeogenesis are the least affected in rpc128-1007 in
agreement with the preference of this mutant to grow on respiratory carbon sources such as glycerol [13].
In a Drosophila melanogaster gut model [116], reduction in RNAP III activity through controlled degrad-
ation of the C160 subunit (C160 encoded by RPC160) leads to diminished protein synthesis. Inhibition of
RNAP III affects RNAP I, but not RNAP II-generated transcripts, suggesting that translation is the major
factor regulating protein abundance in RNAP III compromised cells [116]. This further suggests that the
rpc128-1007 mutant, might be limited at translation and indeed the rpc128-1007 mutant has reduced tRNA
levels [13]. In rpc128-1007, translation seems to be selective towards enzymes in de novo amino acids synthesis
at the expense of the full complement of glycolytic enzymes. As a consequence of decreased abundance of the
glycolytic enzymes, the glycolytic ﬂux is very likely to decrease.
The reduction in abundance of selected glycolytic enzymes, such as Hxk2, Tdh1-3 and Cdc19 in rpc129-1007
is followed by the decrease in their enzymatic activity at high concentrations of glucose (Figures 5 and 6).
Lowering the intracellular Cdc19 concentration is sufﬁcient to shift from fermentative to oxidative metabolism
in yeast, which reduced ﬂux towards pyruvate [69]. The lower abundance and activity of the ﬁrst (Hxk2) and
the last (Cdc19) enzymes in the glycolytic pathway can be expected to reduce glycolytic ﬂux in the mutant.
The RNAP III RET1/C128 mutation elicits a diminution of the low-afﬁnity glucose transporter 1 (activated
on high glucose), the major glucose transporter facilitating glucose uptake under glucose-rich conditions [82]
and which is under control of Rgt2 (low afﬁnity) glucose sensor (Figure 5B). External glucose signaling, may
not be a dominant factor in reprogrammed HXT genes expression in rpc128-1007, glucose metabolism may
dominate in this case [53]. Our data are consistent with the postulate that ‘glucose sensing’ could occur intra-
cellularly [1–4], but not yet (so far) linked to metabolic reprogramming upon change in RNAP III activity.
There is some debate as to whether the signaling molecule for metabolism switching is fructose
1,6-bisphosphate [4,82]. F16BP triggers a switch in metabolism from respiration to fermentation in unicellular
and higher organisms. It is the key metabolic factor determining AMPK/Snf1 kinase activity and is a potent
activator of Ras pathway [3,4,90]. If F16BP plays such key roles, we reasoned that the intracellular concentration
should be lower rpc128-1007 and higher in maf1Δ.
Although signiﬁcantly lower than in the wild-type cells, the levels of F16BP in both mutant strains are com-
parable (Figure 6). This suggested that in maf1Δ, the mechanisms protecting cells from damaging increased
concentrations of glycolytic intermediates are unperturbed thus increasing cells survival; cells capable of
increased glucose consumption.
Despite the initial rise in F16BP after a glucose pulse, the metabolite attains a steady-state concentration at
levels that are not likely to be toxic to the rpc128-1007 mutant. In rpc128-1007 cells, we presume that there is no
direct relationship between intracellular F16BP and the growth defect on glucose medium exhibited by these cells,
however alternative scenario is possible if taking into account the overall abundance of the glycolytic enzymes and
an excess of F16BP which may affect Ras proteins. These cells also exhibit a large decrease in ribosomal proteins
(RP) (Supplementary Table S4). RNAP III transcription is co-ordinately regulated with transcription of rDNA and
ribosomal protein-coding genes [12,117]. Normally ribosomal proteins and their mRNAs are stabilized when yeast
is subject to increased glucose [118]. Arguably, the lower abundance of RP proteins in rpc128-1007 could reduce
the energy expense of cells that are unable to metabolize available extracellular glucose. For the rpc128-1007, all of
the changes at the proteome level are reminiscent of the global changes in yeast cells in response to environmen-
tally stressful, glucose-deprived conditions. An exception is the cohort of proteins of the TCA cycle. RNAP III
compromised cells have reduced glycolysis but this reduction does not lead to enhanced oxidative metabolism.
maf1Δ cells preferentially metabolizes glucose, which results in carbon
overﬂux fueling the side pathways dependent on glycolytic
intermediates as precursors
Lack of Maf1 causes cells to reprogram their metabolism towards higher glycolytic activity when grown under
high glucose conditions. This response is not reﬂected in an increase in abundance of the glycolytic enzymes
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but rather in enzymatic activity. Of course, the proﬁle of activity modulating posttranslational modiﬁcations of
these enzymes could well be different in maf1Δ but this was beyond the scope of this study. For example, hexo-
kinase 2 exhibited higher activity in maf1Δ even though the protein abundance was reduced and the activity of
this enzyme is regulated by phosphorylation [119,120]. Higher hexokinase activity should lead to increased ﬂux
into glycolysis. However, due to robustness of ﬂux regulation, carbon is redistributed in maf1Δ into the side
branches of the glycolytic pathway at glucose-6P (Figure 12). The maf1Δ shows the increased capability to
direct carbon into all the side branch pathways as suggested by the proteomic data and conﬁrmed by direct
metabolite assay (Figure 7A). Glucokinase (Glk1), increased in abundance in maf1Δ, may redirect glucose
toward glycogen storage as previously postulated [121]. The enzymes of glycogen trehalose and central carbon
metabolism may be altered in maf1Δ as these are dependent on control by the major nutrient-sensing protein
kinases TOR, PKA, Snf1, Pho85 and the energy sensor Pas kinase [119,122,123].
In rat hepatoma cells, glucose import, and the activity of hexokinase, hexose phosphate isomerase and the
glucose-6P branches that generate F16BP exert most of the ﬂux control [124]. We believe that in S. cerevisiae,
hexokinase 2 and increased activity of the low-afﬁnity glucose transporter Hxt1 have the greatest potential to
Figure 12. Proposed model of carbon ﬂow in rpc128-1007 and maf1Δ yeast cells.
Altered RNAP III activity affects carbon ﬂux. Low activity of RNAP III in rpc128-1007 strain is correlated with decreased carbon
ﬂow through glycolysis in comparison with reference strain. In contrast, maf1Δ cells demonstrate increased carbon ﬂow
through hexokinase step and lower glycolysis compared with the control strain. In maf1Δ, excess glucose-6-P (G6P) is
redirected into PPP and trehalose and glycogen biosynthesis. As a result, fructose 1,6-bisphosphate (F16BP) concentration
decreases in maf1Δ. From the increased glycerol concentration, carbon ﬂux is partially redirected towards upper glycolysis at
PEP. Green: decrease in carbon ﬂux; Red: increase in carbon ﬂux. Legend: glucose-6-phosphate (G6P); fructose-6-phosphate
(F6P); fructose 1,6-bisphosphate (F16BP); dihydroxyacetone phosphate (DHAP); glyceraldehyde-3-phosphate (G3P);
6-phosphogluconate (6PG); ribose-5-phosphate (R5P); 3-phosphoglyceric acid (3PG); phosphoenolpyruvate (PEP).
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contribute to ﬂux rerouting in maf1Δ. At this stage, we do not know the intracellular signal. The activity of
Hxk2 is elevated even though the trehalose shunt, which acts as a safety valve against excessive supply of
glucose, may correct glucose inﬂux through allosteric inhibition of Hxk2 by trehalose-6P [98,102]. Furthermore,
the glycolytic ﬂux towards pyruvate could be enhanced by Tdh over-activation. However, carbon ﬂux in maf1Δ
fuel the glycerol synthesis pathway rather than causing ethanol accumulation. Glycerol accumulation in maf1Δ
must serve as a drain for excess reducing power, to ameliorate redox imbalance in the cells. MAF1 deletion in
yeast cells is associated with redox imbalance as has previously reported by Bonhoure et al. [125] in MAF1
knockout mice. In S. cerevisiae, this is efﬁciently counteracted by NADH-consuming glycerol formation [126].
Activation of the branch pathways of the central carbon metabolism seen in maf1Δ is a hallmark of cancer
cells that reprogram glycolytic activity towards the synthesis of metabolites required in excess when cells
rapidly divide. For instance, the PP pathway provides precursors for nucleotide and amino acid biosynthesis.
This pathway, also referred to as a metabolic redox sensor, is important to maintain carbon homeostasis, is
highly correlated to oncogenic, nutrient response signaling pathways [104,127–129] and is required for
NADPH regeneration. It supports metabolic reconﬁguration in rapidly proliferating cells since NADPH is a
ubiquitous cofactor for most anabolic reductive reactions and got scavenging of reactive oxygen species (ROS)
that cause oxidative damage to DNA and proteins and which reduce protein synthesis [130,131]. ROS scaven-
ging enzymes also increased in abundance in maf1Δ, suggesting a role of Maf1 in the regulation of intracellular
redox potential.
How is the glucose ﬂux distributed in Maf1-deﬁcient yeast cells? We propose a scenario, built on our obser-
vation of the decreased levels of the allosteric activator of pyruvate kinase Cdc19. The reduced F16BP concen-
tration in maf1Δ cells could adversely affect Cdc19 activity. Cdc19 activity dependency on the F16BP
availability for binding [93–95], but not Cdc19 abundance per se or phosphorylation, plays a predominant role
in regulating the metabolic ﬂux through the pyruvate kinase Cdc19 [96]. Previously published data, on the
effect of MAF1 deletion on Cdc19 activity did not agree, possible because that study lacked estimation of the
intracellular concentration of F16BP (involved in Cdc19 regulation by ultrasensitive allostery) but also lacked
data on ﬂuxes into the exometabolome, speciﬁcally trehalose, glycogen and glycerol ﬂuxes [132]. The previous
result [132], is controversial since there is much lower activity of Cdc19 in the reference strain on glycerol in in
vitro assay done under conditions of saturating concentration of F16BP. This impacts on the overall activity of
Cdc19 in maf1Δ cells, which is compared with Cdc19 activity in the reference strain.
Since F16BP levels are low in maf1Δ (Figure 6), this may further lead to decrease in Cdc19 activity in vivo
and pushing the glycolytic intermediated of lower glycolysis back to upper side branches of the pathway since
lower PEP/pyruvate conversion, catalyzed by pyruvate kinase, favors accumulation of glycolytic intermediates,
refueling diverging anabolic pathways, such as the pentose phosphate pathway (PPP) and serine biosynthesis
[90,133].
In our model, the glycolytic ﬂux bypasses the steps in upper glycolysis between G6P and G3P, achieved via
improved ﬂux through PPP. This pathway operates in three modes, depending on a cell demand for metabolic
intermediates and cofactors. To avoid extensive F16BP synthesis, which would improve cells survival, the ﬂux
should be directed towards glyceraldehydes (G3P) [4]. This scenario is supported by our observation of glycerol
accumulation and no change in ethanol production in maf1Δ cells. This glucose ﬂux redistribution towards the
PPP shunt, amino acids and nucleotide biosynthesis, due to Cdc19 action has been reported for cancer cells
[134]. Furthermore, human ﬁbroblasts exposed to hydrogen peroxide elicit enhanced carbon ﬂow through
upper glycolysis and the oxidative branch of PPP, causing reduction in lower glycolysis activity [135].
The characteristics of maf1Δ in central carbon metabolism is reminiscent of cancer proliferating mammalian
cells which are stimulated in the early part of glycolysis via PI3K/AKT activation, and making glycolytic inter-
mediates available for macromolecular synthesis due to the low-activity isoform of PK-M2 pyruvate kinase and
producing NADPH due to mutated p53 tumor suppressor [133,134].
There are further similarities between maf1Δ and mammalian cells after oncogenic transformation. We
noted increased potential for amino acid biosynthesis, including the arginine and leucine metabolic pathways.
Arg and Leu are crucial for TORC1 signaling and activation of protein translation in yeast and higher eukar-
yotes. Leucine is the most frequently encoded amino acid in eukaryotic genomes and its levels are sensed by
leucyl-tRNA synthetase to activate TORC1 kinase [136,137]. How yeast TORC1 integrates arginine signals is
presently unknown. In mammals, arginine levels are communicated by two mechanisms, involving Rag
GTPases mediating amino acids signals to control mTORC1 and by a cytoplasmic mechanism that involves
arginine signaling by a sensor called CASTOR [138,139].
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maf1Δ cells have also a strong enrichment in the branch of serine/cysteine, methionine biosynthesis pathway
and in sulfate metabolism by contrast with rpc128-1007 cells. Methionine biosynthesis is connected to tRNA
quality control [140]. A crucial contribution of serine/glycine to cellular metabolism is through the glycine
cleavage system, which resupplies once carbon units for one-carbon metabolism. The importance of serine/
glycine metabolism is emphasized by genetic and functional evidence indicating that hyperactivation of the
serine/glycine biosynthetic pathway drives oncogenesis. During growth on a fermentable carbon source, most
serine is derived from the phosphoglycerate-3P by the gene products Ser3 and Ser33. Ser3 is a cytosolic
enzyme with the dual function of phosphoglycerate dehydrogenase and α-ketoglutarate reductase [141]. Known
for oxidizing 3-phosphoglycerate in the main serine biosynthesis pathway Ser3 also reduces α-ketoglutarate to
D-2-hydroxyglutarate (D-2HG) using NADH, the major intracellular source of D-2HG in yeast. High levels
of intracellular D-2HG are found in several types of cancer including gliomas and acute myelogenous
leukemia [142].
RNAP III genes are not equally regulated by Maf1. Comparison of expression of selected tDNA genes in
maf1Δ on glucose has revealed elevated tRNAMet levels [13]. Methionine is a proteinogenic amino acid.
Overexpression of initiator methionine tRNA (tRNAMet) leads to reprogramming of tRNA expression and
increased cell metabolic activity in Drosophila and proliferation in human epithelial cells [143,144]. Moreover,
methionine metabolism inﬂuences genomic architecture via H3K4me3 histone methylation to alter chromatin
dynamics and cancer-associated gene expression [145]. Furthermore, high methionine metabolism and sulfur
utilization is intertwined with high Tkl1 transketolase activity and is dependent on the non-oxidative phase of
the PPP, Tkl1 abundance increased under our study in maf1Δ [146]. Methionine biosynthesis, via the assimila-
tion of inorganic sulfate, requires three molecules of NADPH per molecule of methionine [106]. The data pre-
sented here suggest that efﬁcient supply of NADPH derived from the PPP in maf1 may also support
methionine biosynthesis in the mutant.
Finally, the proteomics data obtained here with glucose-grown maf1Δ, suggest an alternative explanation to
the reduced ﬁtness of this strain on non-fermentable carbon sources. Down-regulation of FBP1 transcription
[52] is unlikely to be the major cause of maf1Δ lethality when grown on glycerol. The FBP1 gene is expressed
only in the absence of glucose, and even if it is not expressed under glucose-rich condition, that is, under this
study the Fbp1 protein is still present in maf1Δ at wild-type levels. It is possible that the growth defect in
maf1Δ on glycerol is due to decrease in abundance of the enzymes involved in the glyoxylate cycle.
In conclusion, global label-free proﬁling of enzymatic proteins in yeast has provided new insight into meta-
bolic physiology. Protein abundance patterns characterized in the mutant strains that show different phenotypes
on fermentable and non-fermentable carbon source highlighted metabolic pathways that could now be the
target for further genetic or metabolic analysis. This work emphasizes S. cerevisiae as a very good model organ-
ism for systems-level studies on the dynamics of cellular networks. There is growing evidence for contradictory
observations in cultured human cancer cells and in multicellular organisms including mouse models [125,145].
We anticipate that yeast cells will continue to be appreciated as a source of basic biological information in
building an integrated picture of metabolism and gene regulation.
Conclusions
• The capacity of the glycolytic pathway can be altered by manipulation of RNAP III activity.
• Lack of Maf1, the negative regulator of RNAP III driven non-coding RNA transcription, enhances glycolytic
ﬂux and results in accumulation of end products upstream of pyruvate.
• Severe reduction in growth rate caused by RNAP III mutation rpc128-1007 on glucose is correlated with a
decrease in the abundance of glycolytic enzymes.
• The translation machinery in the rpc128-1007 mutant seems to be selective towards mRNA coding for
enzymes for amino acids synthesis de novo at the expense of full complement of glycolytic enzymes.
• The critical decrease in abundance of glyoxylate cycle enzymes reduced the ability to convert
non-fermentable substrates in MAF1 knockout yeast.
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supplemented with 2% glycerol; Zwf1, glucose-6-phosphate dehydrogenase.
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